SABS

SAB Biotherapeutics, Inc. [SABS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SABS Stock Summary

Top 10 Correlated ETFs

SABS


Top 10 Correlated Stocks

SABS


In the News

SABS Financial details

Company Rating
-
Market Cap
43.13M
Income
-42.24M
Revenue
2.24M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
57
Optionable
No
Shortable
Yes
Earnings
14 May 2024
P/E
-11.42
Forward P/E
-
PEG
-1.47
P/S
1.43
P/B
20.4
P/C
-
P/FCF
0.87
Quick Ratio
0.26
Current Ratio
0.34
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-7.66
EPS next Y
-
EPS next Q
-
EPS this Y
77.26%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
103.3%
Revenue last 5Y
-8.24%
Revenue Q/Q
-75.93%
EPS Q/Q
297.94%
-
-
-
-
SMA20
100%
SMA50
-
SMA100
-33.33%
Inst Own
-
Inst Trans
-
ROA
-96%
ROE
-121%
ROC
-1.41%
Gross Margin
100%
Oper. Margin
-661%
Profit Margin
-666%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.0-14.5
52W High
-87.93%
52W Low
-57.75%
RSI
59
Rel Volume
0.69
Avg Volume
16.77K
Volume
11.56K
Perf Week
23.36%
Perf Month
6.29%
Perf Quarter
-57.22%
Perf Half Y
-42.12%
-
-
-
-
Beta
0.801
-
-
Volatility
0.09%, 0.2%
Prev Close
2.11%
Price
1.69
Change
2.92%

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap